Meditect regularly publish editorial content on its blog, available on Medium!
In this personal column, Arnaud looks back on the genesis of Meditect and its evolution. He also presents the company’s commitment to the fight against counterfeit drugs in the coming years.
Following his victory in the BFM Academy final, Romain is interviewed by Christophe Jakubyszyn and Sandra Gandoin to talk about the stakes involved in counterfeit drug trafficking, and Meditect's ambitions for the future.
They were only four out of the 800 young companies originally engaged in the BFM Business competition. During the final held live on October 12, Meditect won the award, with more than 40% of the online votes. It’s a first in the history of the competition.
Arnaud was invited by Fabien Guez on the « Check up Santé » programme to raise awareness about the trafficking of falsified medicines in sub-Saharan. He also presents the more than convincing results of Meditect in Côte d’Ivoire, and the ambition to become a key player in the access to safe medicines for patients in the region.
Focusing this year on projects with positive impact on society, the annual Digital InPulse competition organised by Huawei, the Richelieu Committee, Business France and the French Tech network, rewarded Meditect for its commitment to the fight against falsified medicines.
Arnaud, who has been living in Abidjan for more than a year, testifies about the situation in Africa with regard to COVID-19, and presents Meditect’s commitment in the fight against fake medicines.
Interviewed by Eva Ben-Saadi and Emilie Kovacs in the program « Smart Impact », Romain present Meditect and talks about the immense challenge of counterfeit medicine trafficking. He explains how the whole Meditect team works every day to fight this public health scourge.
After a first round in 2019 with business angels, BPI Nouvelle-Aquitaine and the Nouvelle-Aquitaine Region, the Bordeaux-based startup is closing its first institutional fund-raising with LBO France through its Digital Health 2 fund.
« Meditect is particularly interested in the last link of the distribution chain: the pharmacist and the patient. No technology can be deployed effectively without a continuous and reinforced presence on the field. Meditect opened its subsidiary in Abidjan in August 2019 and continues to recruit employees to be in contact with pharmacists and patients. ». Meditect is proud to sponsor the 1st Congress of the National Union of Private Pharmacists of Ivory Coast. Over 400 pharmacy owners gathered at the Heden Golf Hotel to discover the latest pharma innovations, discuss developments in the private sector and the issue of street medicines.
Romain Renard is invited to present the blockchain technology developed by Meditect during the BPI Deeptech Tour in Bordeaux. It is from a need in the field that we have identified blockchain as the optimal solution to tackle the safety issues related to the distribution of medicines that need to be addressed.
Having received support from the ecosystem of the Nouvelle-Aquitaine region (grant Digital Prototyping, support from the Unitec accelerator) since 2017, Meditect is diversifying its funds through aid from the region and Bpifrance Nouvelle-Aquitaine to accelerate its research.
« Blockchain is a virtuous technology: it ensures robustness, immutability and transparency, three essential criteria for securing a supply chain. » Arnaud Pourredon is one of the speakers at TEDx Abidjan. He presents the blockchain technology used by Meditect to secure and optimize the medicine supply chain.
“Labelling, serialization, authentication: what solutions are available and how can Customs benefit from them?” For the 16th consecutive year, the WCO held its counterfeiting conference (Counterfeiting and Piracy Group). Romain Renard presents the innovative solution developed by Meditect, which enables unit-level medicines’ identification and a better monitoring of their distribution.
Meditect is invited to present its solution for securing and optimizing medicine distribution.
EIT Health is one of the “Knowledge and Innovation Communities”, or KICs, around the theme of health, launched and funded by the European Institute of Innovation and Technology (EIT) in 2015. Each year, the most innovative start-ups are chosen after a selective process to join the EIT network and benefit from the expertise of more than 140 academic and industrial partners across Europe. Meditect is one of the selected French start-ups and thus joined the EIT network.
The Meditect start-up, specialized in medicine traceability, announces the signing of an agreement with UPSA, marking the first time its solution has been launched on the market. As part of the implementation of a pilot project in Ivory Coast, Meditect will improve the traceability of UPSA medicines. The start-up will thus enable patients and pharmacists to check the authenticity of these medicines thanks to free applications, accessible via smartphone. The deployment of Meditect is initially planned for one of the most widely used medicines in West Africa.
Meditect participates in the first international trade show dedicated to the fight against medicine counterfeiting. Held in Zurich, this forum brings together hundreds of specialists of the fight against counterfeiting from various fields (industrial, academic, institutional). Meditect is presented by Romain Renard in a plenary session.
Despite very strong competition, the social impact of the project was convincing, and the first prize was awarded to Meditect to support its development. The entire team is very proud of this recognition, especially Romain Renard, co-founder of Meditect and Sciences Po alumni.
Created in 2002, the “Alliance Programme” is an academic partnership between Columbia University and three prestigious French institutions: University Paris I Panthéon-Sorbonne, École Polytechnique and Sciences Po Paris. Its objective is to foster exchanges between these four institutions through numerous initiatives, including the “Blockchain Innovation Challenge”. Meditect had the privilege of representing Sciences Po at the final of the 1st edition of this competition and answered questions from journalists in New York City.
PharmagoraPlus, European pharmacy trade show, welcomes nearly 14,000 healthcare professionals and 400 companies to discuss the new challenges in the field. Meditect proudly presents its solution to fight falsified medicine trafficking.
Every year, Forbes magazine publishes a ranking of the thirty most influential European personalities under the age of thirty in the fields of finance, media, technology and health. Arnaud Pourredon is listed in the “Science and Healthcare” category and is honored to represent Meditect in its fight against the falsified medicine scourge.
In October 2018, following its active participation in various trade shows, Meditect caught the attention of Spanish media « The Daily Prosper », that produced a video presenting Meditect (in Spanish). The video report portrays the daily life in Côte d’Ivoire and introduces Arnaud Pourredon, co-founder of Meditect, discussing the current problem of falsified medicines in West Africa and explaining how Meditect’s solution aims to fight this scourge and improve public health thanks to blockchain technology.